Atropine treatment modifies LPS-induced inflammatory response and increases survival

Inflammation Research

Volumn 57, Issue 3, 2008, Pages 111-117

  Fuentes, J M ^a   Fulton, W B ^a   Nino, D ^b   Talamini, M A ^b   Maio, A De ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Cytokines; Endotoxin; Inflammation; Sepsis; Shock

Indexed keywords

ATROPINE; BACTERIUM LIPOPOLYSACCHARIDE; INTERLEUKIN 10; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOLOGICAL MONITORING; CONTROLLED STUDY; DRUG EFFECT; ENDOTOXEMIA; INFLAMMATORY INFILTRATE; KAPLAN MEIER METHOD; LOG RANK TEST; MALE; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL; SURVIVAL RATE; SURVIVAL TIME; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE;

ANIMALS; ATROPINE; INTERLEUKIN-10; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED C57BL; MUSCARINIC ANTAGONISTS; NF-KAPPA B; SHOCK, SEPTIC; SURVIVAL RATE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 41449108075     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-007-7134-y     Document Type: Article

References (34)

1. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001; 29: 1303-10.
2. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med 2003; 348: 138-50.
3. Sands KE, Bates DW, Lanken PN, Graman PS, Hibberd PL, Kahn KL et al. Epidemiology of sepsis syndrome in 8 academic medical centers. Academic Medical Center Consortium Sepsis Project Working Group. Jama 1997; 278: 234-40.
4. Cohen J. The immunopathogenesis of sepsis. Nature 2002; 420: 885-91.
5. Ulevitch RJ, Tobias PS. Recognition of gram-negative bacteria and endotoxin by the innate immune system. Curr Opin Immunol 1999; 11: 19-22.
6. Dinarello CA. Proinflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of septic shock. Chest 1997; 112: 321S-329S.
7. Hotchkiss RS, Tinsley KW, Karl IE. Role of apoptotic cell death in sepsis. Scand J Infect Dis 2003; 35: 585-92.
8. Zeni F, Freeman B, Natanson C. Anti-inflammatory therapies to treat sepsis and septic shock: a reassessment. Crit Care Med 1997; 25: 1095-100.
9. Sternberg EM. Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens. Nat Rev Immunol 2006; 6: 318-28.
10. Tracey KJ. The inflammatory reflex. Nature 2002; 420: 853-9.
11. Borovikova LV, Ivanova S, Zhang M, Yang H, Botchkina GI, Watkins LR et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 2000; 405: 458-62.
12. Pavlov VA, Ochani M, Gallowitsch-Puerta M, Ochani K, Huston JM, Czura CJ et al. Central muscarinic cholinergic regulation of the systemic inflammatory response during endotoxemia. Proc Natl Acad Sci U S A 2006; 103: 5219-23.
13. Fuentes JM, Talamini MA, Fulton WB, Hanly EJ, Aurora AR, De Maio A. General anesthesia delays the inflammatory response and increases survival for mice with endotoxic shock. Clin Vaccine Immunol 2006; 13: 281-8.
14. Rongione AJ, Kusske AM, Ashley SW, Reber HA, McFadden DW. Interleukin-10 prevents early cytokine release in severe intraabdominal infection and sepsis. J Surg Res 1997; 70: 107-12.
15. Goodman L. Goodman & Gilman's The Pharmacological Basis of Therapeutics, 11th Edition: McGraw-Hill, New York, NY, 2006: xxiii.
16. Das G. Therapeutic review. Cardiac effects of atropine in man: an update. Int J Clin Pharmacol Ther Toxicol 1989; 27: 473-7.
17. De Maio A, Mooney ML, Matesic LE, Paidas CN, Reeves RH. Genetic component in the inflammatory response induced by bacterial lipopolysaccharide. Shock 1998; 10: 319-23.
18. Dignam JD, Lebovitz RM, Roeder RG. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 1983; 11: 1475-89.
19. Alaish SM, Torres M, Ferlito M, Sun CC, De Maio A. The severity of cholestatic injury is modulated by the genetic background. Shock (Augusta, Ga 2005; 24: 412-6.
20. Wang H, Yu M, Ochani M, Amella CA, Tanovic M, Susarla S et al. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 2003; 421: 384-8.
21. Fuentes JM, Hanly EJ, Aurora AR, De Maio A, Shih SP, Marohn MR et al. CO2 abdominal insufflation pretreatment increases survival after a lipopolysaccharide-contaminated laparotomy. J Gastrointest Surg 2006; 10: 32-8.
22. Fuentes JM, Hanly EJ, Aurora AR, De Maio A, Talamini MA. Anesthesia-specific protection from endotoxic shock is not mediated through the vagus nerve. Surgery 2005; 138: 766-71.
23. Molina PE. Neurobiology of the stress response: contribution of the sympathetic nervous system to the neuroimmune axis in traumatic injury. Shock 2005; 24: 3-10.
24. van der Poll T, Coyle SM, Barbosa K, Braxton CC, Lowry SF. Epinephrine inhibits tumor necrosis factor-alpha and potentiates interleukin 10 production during human endotoxemia. J Clin Invest 1996; 97: 713-9.
25. Zinyama RB, Bancroft GJ, Sigola LB. Adrenaline suppression of the macrophage nitric oxide response to lipopolysaccharide is associated with differential regulation of tumour necrosis factor-alpha and interleukin-10. Immunology 2001; 104: 439-46.
26. Madden KS, Sanders VM, Felten DL. Catecholamine influences and sympathetic neural modulation of immune responsiveness. Annu Rev Pharmacol Toxicol 1995; 35: 417-48.
27. Heneka MT, Gavrilyuk V, Landreth GE, O'Banion MK, Weinberg G, Feinstein DL. Noradrenergic depletion increases inflammatory responses in brain: effects on IkappaB and HSP70 expression. J Neurochem 2003; 85: 387-98.
28. Metz CN, Tracey KJ. It takes nerve to dampen inflammation. Nat Immunol 2005; 6: 756-7.
29. de Jonge WJ, van der Zanden EP, The FO, Bijlsma MF, van Westerloo DJ, Bennink RJ et al. Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway. Nat Immunol 2005; 6: 844-51.
30. Kawashima K, Fujii T. Extraneuronal cholinergic system in lymphocytes. Pharmacol Ther 2000; 86: 29-48.
31. Kawashima K, Fujii T. The lymphocytic cholinergic system and its biological function. Life Sci 2003; 72: 2101-9.
32. Kawashima K, Fujii T. Expression of non-neuronal acetylcholine in lymphocytes and its contribution to the regulation of immune function. Front Biosci 2004; 9: 2063-85.
33. Marks JD, Marks CB, Luce JM, Montgomery AB, Turner J, Metz CA et al. Plasma tumor necrosis factor in patients with septic shock. Mortality rate, incidence of adult respiratory distress syndrome, and effects of methylprednisolone administration. Am Rev Respir Dis 1990; 141: 94-7.
34. Grabovoi AN. The vascularization of skin connective-tissue regenerates during wound healing under exposure to neurotransmitters and their antagonists. Morfologiia 1997; 111: 73-6.